Rifampicin 300 mg (Rimactan ”Pliva”); tilladelse til ordination og udlevering af udenlandske pakninger
Safety Classified by Officially
Inaktivering - Lægemiddelstyrelsen inaktiverer d. 26. oktober tilladelse til ordination og udlevering af Rimactan "Pliva" kapsler, hårde 300 mg efter lægemiddellovens § 29, stk. 2, da markedsførte pakninger igen er tilgængelige.
Source: Lægemiddelstyrelsen.
Read the original at the source: https://laegemiddelstyrelsen.dk/da/godkendelse/kontrol-og-inspektion/mangel-paa-medicin/udenlandske-laegemidler-som-kan-udleveres-efter-laegemiddellovens-29,-stk-2/rifampicin-300-mg-rimactan-pliva-tilladelse-til-ordination-og-udlevering-af-udenlandske-pakninger/
Officially imported this from Lægemiddelstyrelsen’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
This publication has changed since it was first published
2 versions recorded. The original is kept in full — nothing is overwritten.
- v2 imported change on current
- v1 as first published on
Provenance
- Organization
- Lægemiddelstyrelsen — imported from official source
- Official source
- https://laegemiddelstyrelsen.dk/da/Feeds/rss-feed/ RSS
- Imported
- October 21, 2026 13:33
- Versions
- 2 recorded
- Identity
-
D3338BE120F34ADB92C1099DB2B85FEB